Research


February 9, 2024

NIH Funds Study of UAMS Nurses’ Influence on Heart Failure Patient Outcomes

David Robinson

Tremaine Williams, Ed.D., at his desk at UAMS.

A University of Arkansas for Medical Sciences (UAMS) research team led by Tremaine Williams, Ed.D., has received a National Institutes of Health (NIH) grant to better understand how nurses influence outcomes of heart failure patients. About 6.2 million people in the United States have heart failure. The two-year, $406,897 R21 grant from the NIH National…


January 19, 2024

Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute

Marty Trieschmann

Dr. Michael Birrer speaks with a patient during a clinic visit

An experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has given a Little Rock man with resistant kidney cancer a complete remission. Dwight Hamilton, 58, battled stage 4 renal cell carcinoma for four years. His cancer returned multiple times even after receiving…


December 15, 2023

UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

UAMS Researcher Takes Aim at Drug-Resistant Myeloma

David Robinson

Fenghuang (Frank) Zhan, M.D., Ph.D.

  UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…


Expanding the Field: Clinical Trials Diversity Benefits Myeloma Research

Nathan Tidwell

Samer Al Hadidi, M.D.

Clinical trials have long been an established part of medical research. The University of Arkansas for Medical Sciences (UAMS) Myeloma Center and the Clinical Trials Office work together to create a more diverse pool of clinical trial participants in the continuing research of multiple myeloma. Samer Al Hadidi, M.D., is a driving force in this…


October 23, 2023

Five UAMS Researchers Awarded Grants for Breast Cancer Research

Marty Trieschmann

UAMS professor Ping-Ching Hsu, Ph.D.,

For the 26th year during Breast Cancer Awareness Month, the Arkansas Breast Cancer Research Program (ABCRP) has awarded funding to kick-start promising breast cancer research projects. Since the passage of the Arkansas Breast Cancer Act in 1997 that created the ABCRP, the Arkansas State Legislature has set aside funds that UAMS invests in novel research…


September 25, 2023

UAMS Division of Research and Innovation Engages Researchers at Orientation and Administrative Showcase

David Robinson

Christy Simecka, DACLAM, D.V.M., (front left), director, Division of Laboratory Animal Medicine, speaks with Susan Steelman, MLIS, AHIP; and (back left) Kerrey Roberto, director, Institutional Animal Care and Use Committee, talks to Dirk Haselow, M.D.

UAMS research faculty got to hear directly from Division of Research and Innovation staff during a fun and informative afternoon that featured brief presentations and concluded with a poster session and reception with drinks and light hors d’oeuvres.


August 3, 2023

UAMS’ Michael Birrer, M.D., Ph.D., Contributes to Major Ovarian Cancer Discovery; Findings Published in Cell

Marty Trieschmann

Dr. Michael Birrer standing in the lobby of the Winthrop P. Rockefeller Cancer Institute at UAMS

The Birrer Laboratory at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute helped discover a proteogenomic signature in ovarian cancer that may improve the way the disease is treated around the world. The discovery, which identifies a 64-protein-gene signature that can predict primary treatment resistance in patients with high grade…


August 1, 2023

National Cancer Institute Awards UAMS Researchers $2.26 Million to Continue Multiple Myeloma Study

Nathan Tidwell

Bellido, Delgado-Calle

LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researchers Teresita Bellido, Ph.D., and Jesus Delgado-Calle, Ph.D., recently received a five-year, $2.26 million continuation award from the National Cancer Institute. Bellido is a professor and chair of the Department of Physiology and Cell Biology in the UAMS College of Medicine, while Delgado-Calle is an…


July 12, 2023

American Cancer Society Funds UAMS Study to Understand Treatment Resistance in Pancreatic Cancer

Marty Trieschmann

UAMS Radiation Oncology Adam Wolfe standing in front of a radiation machine in the new UAMS Radiation Oncology Center

Adam Wolfe, M.D., Ph.D., a radiation oncologist at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has received a $583,200 grant from the American Cancer Society (ACS) to study radiation resistance in pancreatic cancer, a lethal disease with the highest mortality rate of all cancers. The four-year ACS Clinician Science…



Next page